A phase III double-blind, placebo-controlled, randomized withdrawal trial of 5‑aminolevulinic acid hydrochloride with sodium ferrous citrate for efficacy and safety in patients diagnosed as Leigh syndrome. - Ohtake, Akira; Abe, Yuichi; Murayama, Kei; Shiraishi, Hideaki; Osaka, Hitoshi; Kumada, Satoko; Ito, Tetsuya; Kondo, Hidehito; Hamada, Yusuke; Suzuki-Ajihara, Sayaka; Arao, Masato; Ueda, Yuki; et al. (PLoS ONE, 2026)